Publicacións (495) Publicacións nas que participase algún/ha investigador/a

2020

  1. (p)ppGpp and its role in bacterial persistence: New challenges

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 10

  2. 5-2-1 Criteria: A Simple Screening Tool for Identifying Advanced PD Patients Who Need an Optimization of Parkinson's Treatment

    Parkinson's Disease, Vol. 2020

  3. 6-Arylmethylidene Penicillin-Based Sulfone Inhibitors for Repurposing Antibiotic Efficiency in Priority Pathogens

    Journal of Medicinal Chemistry, Vol. 63, Núm. 7, pp. 3737-3755

  4. A Comparative Study of Doppler Ultrasound against Temporal Artery Biopsy in the Diagnosis of Giant Cell Arteritis

    Reumatologia Clinica, Vol. 16, Núm. 5P1, pp. 313-318

  5. A Contemporary Picture of Enterococcal Endocarditis

    Journal of the American College of Cardiology, Vol. 75, Núm. 5, pp. 482-494

  6. A Multi-omic Integrative Scheme Characterizes Tissues of Action at Loci Associated with Type 2 Diabetes

    American Journal of Human Genetics, Vol. 107, Núm. 6, pp. 1011-1028

  7. A Pathogenic Galactosidase A Mutation Coexisting With an MYBPC3 Mutation in a Female Patient With Hypertrophic Cardiomyopathy

    Canadian Journal of Cardiology, Vol. 36, Núm. 9, pp. 1554.e1-1554.e3

  8. A Senescence-Centric View of Aging: Implications for Longevity and Disease

    Trends in Cell Biology, Vol. 30, Núm. 10, pp. 777-791

  9. A case of severe hypothermia following three-month administration of paliperidone palmitate: a case report

    Actas espanolas de psiquiatria, Vol. 48, Núm. 4, pp. 181-190

  10. A case report of primary cardiac fibroma: An effective approach for diagnosis and therapy of a pathologically benign tumour with an unfavourable prognosis

    European Heart Journal - Case Reports, Vol. 4, Núm. 4, pp. 1-5

  11. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1

  12. A live auxotrophic vaccine confers mucosal immunity and protection against lethal pneumonia caused by Pseudomonas aeruginosa

    PLoS Pathogens, Vol. 16, Núm. 2

  13. A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

    Annals of Oncology, Vol. 31, Núm. 12, pp. 1734-1745

  14. A new scenario in metastatic renal cell carcinoma: a SOG-GU consensus

    Clinical and Translational Oncology, Vol. 22, Núm. 9, pp. 1565-1579

  15. A reference map of potential determinants for the human serum metabolome

    Nature, Vol. 588, Núm. 7836, pp. 135-140

  16. A systematic review on the effectiveness of anti-choking suction devices and identification of research gaps

    Resuscitation, Vol. 153, pp. 219-226

  17. ASTRIS, a large real-world study to evaluate the efficacy of osimertinib in epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer patients: Clinical characteristics and genotyping methods in a Spanish cohort

    Revista Espanola de Patologia, Vol. 53, Núm. 3, pp. 140-148

  18. Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients

    Rheumatology (Oxford, England), Vol. 59, Núm. 12, pp. 3906-3916

  19. Activity of imipenem-relebactam against a large collection of pseudomonas aeruginosa clinical isolates and isogenic β-lactam-resistant mutants

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 2

  20. Adherence to prophylaxis in adult patients with severe haemophilia A

    Haemophilia, Vol. 26, Núm. 5, pp. 800-808